Radiation-sensitizing effect of low-concentration docetaxel on human esophageal squamous cell carcinoma cell lines

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 601-606

Spandidos Publications

Access to resources Recommend Favorite

Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study

By Tanaka Yoshihiro   Yoshida Kazuhiro   Sanada Yuichi   Osada Shinji   Yamaguchi Kazuya   Takahashi Takao  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1159-1165

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of docetaxel, cisplatin and S1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 898-904

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

By Samlowski Wolfram E.   Moon James   Kuebler J. Philip   Nichols Craig R.   Gandara David R.   Ozer Howard   Williamson Stephen K.   Atkins James N.   Schuller David E.   Ensley John F.  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 182-188

Informa Healthcare

Access to resources Recommend Favorite

Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma

By Rahadiani Nur  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1311-1323

Springer Publishing Company

Access to resources Recommend Favorite